Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01639040
What this trial is testing

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT06810050
What this trial is testing

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 180
Early research (Phase 1)Looking for participantsNCT06982352
What this trial is testing

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic Dermatitis (AD)Psoriasis (PsO)
LAPIX Therapeutics Inc. 48
Early research (Phase 1)Looking for participantsNCT07455578
What this trial is testing

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Who this might be right for
Autoimmune DiseasesRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)+3 more
Seismic Therapeutic AU Pty Ltd 24
Testing effectiveness (Phase 2)UnknownNCT04725136
What this trial is testing

Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT05149313
What this trial is testing

Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

Who this might be right for
Dermatitis, AtopicEczema
Almirall, S.A. 331
Not applicableNot Yet RecruitingNCT07276620
What this trial is testing

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Who this might be right for
Atopic Dermatitis (AD)
Xiangya Hospital of Central South University 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07386743
What this trial is testing

A Phase III Study of GS101 Injection to Dupixent®

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd 572
Testing effectiveness (Phase 2)Study completedNCT03359356
What this trial is testing

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 60
Not applicableStudy completedNCT02357940
What this trial is testing

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Who this might be right for
Atopic Dermatitis (AD)
Johnson & Johnson Consumer Inc. (J&JCI) 41
Not applicableStudy completedNCT05959083
What this trial is testing

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
AbbVie 200
Large-scale testing (Phase 3)Study completedNCT02896101
What this trial is testing

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Glenmark Pharmaceuticals Ltd. India 755
Testing effectiveness (Phase 2)Study completedNCT04922021
What this trial is testing

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
LEO Pharma 58
Large-scale testing (Phase 3)Study completedNCT01244230
What this trial is testing

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Sanofi 100
Testing effectiveness (Phase 2)Study completedNCT02564055
What this trial is testing

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 247
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Large-scale testing (Phase 3)Not Yet RecruitingNCT07162896
What this trial is testing

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Dermatitis (AD)
Shalamar Institute of Health Sciences 66
Testing effectiveness (Phase 2)Ended earlyNCT05935085
What this trial is testing

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Who this might be right for
Atopic Dermatitis Eczema
AnaptysBio, Inc. 201
Not applicableStudy completedNCT07066150
What this trial is testing

A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement

Who this might be right for
Atopic Dermatitis (AD)PsoriasisAcne Vulgaris+4 more
Shanghai Chicmax Cosmetic Co., Ltd. 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Next Page